Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.45B |
| 2 |
Apple
AAPL
|
+$814M |
| 3 |
NVIDIA
NVDA
|
+$700M |
| 4 |
Broadcom
AVGO
|
+$647M |
| 5 |
Shopify
SHOP
|
+$593M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$701M |
| 2 |
Johnson & Johnson
JNJ
|
+$685M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$484M |
| 4 |
Meta Platforms (Facebook)
META
|
+$407M |
| 5 |
HubSpot
HUBS
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.47% |
| 2 | Financials | 12.85% |
| 3 | Industrials | 11.86% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Healthcare | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Regional Management Corp
RM
$291M
| $417K | ﹤0.01% |
14,278
-1,104
| -7% | -$32.1K |
|
|
ONL
3177
Orion Office REIT
ONL
$157M
| $415K | ﹤0.01% |
194,659
-56,674
| -23% | -$108K |
|
3178
Magnachip Semiconductor
MX
$134M
| $415K | ﹤0.01% |
104,166
-49,130
| -32% | -$171K |
|
3179
Tactile Systems Technology
TCMD
$657M
| $414K | ﹤0.01% |
40,827
+5,190
| +15% | +$59.3K |
|
3180
Altimmune
ALT
$593M
| $414K | ﹤0.01% |
106,863
+25,735
| +32% | +$139K |
|
3181
BRC Group Holdings
RILY
$292M
| $413K | ﹤0.01% |
139,191
-22,603
| -14% | -$69.5K |
|
3182
RBB Bancorp
RBB
$448M
| $412K | ﹤0.01% |
23,921
-8,153
| -25% | -$133K |
|
3183
Foster
FSTR
$414M
| $410K | ﹤0.01% |
18,765
-6,639
| -26% | -$130K |
|
3184
Choiceone Financial
COFS
$508M
| $410K | ﹤0.01% |
14,282
+1,573
| +12% | +$44.6K |
|
3185
Waterstone Financial
WSBF
$370M
| $410K | ﹤0.01% |
29,677
-5,800
| -16% | -$74.2K |
|
|
TRML
3186
DELISTED
Tourmaline Bio
TRML
| $410K | ﹤0.01% |
25,626
+5,706
| +29% | +$92.4K |
|
3187
dLocal
DLO
$4.23B
| $408K | ﹤0.01% |
35,987
-10,387
| -22% | -$102K |
|
3188
BlackRock MuniAssets Fund
MUA
$519M
| $408K | ﹤0.01% |
39,217
+30
| +0.1% | +$308 |
|
3189
Savers
SVV
$1.89B
| $406K | ﹤0.01% |
39,781
+2,224
| +6% | +$21.8K |
|
3190
WisdomTree US MidCap Dividend Fund
DON
$4.08B
| $405K | ﹤0.01% |
8,084
-645
| -7% | -$31.1K |
|
3191
Centuri Holdings
CTRI
$2.4B
| $405K | ﹤0.01% |
18,041
+4,962
| +38% | +$97K |
|
3192
JELD-WEN Holding
JELD
$162M
| $403K | ﹤0.01% |
102,899
+22,746
| +28% | +$101K |
|
|
PFO
3193
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$119M
| $403K | ﹤0.01% |
43,592
+6,372
| +17% | +$56.9K |
|
3194
Civeo
CVEO
$330M
| $403K | ﹤0.01% |
17,459
-4,147
| -19% | -$87.7K |
|
3195
Park Aerospace
PKE
$801M
| $403K | ﹤0.01% |
27,293
-3,449
| -11% | -$46.7K |
|
3196
Xeris Biopharma Holdings
XERS
$1.46B
| $403K | ﹤0.01% |
86,194
-940,644
| -92% | -$4.31M |
|
3197
Health Catalyst
HCAT
$129M
| $401K | ﹤0.01% |
106,368
+8,769
| +9% | +$34.5K |
|
3198
First Bank
FRBA
$452M
| $400K | ﹤0.01% |
25,886
-2,782
| -10% | -$40.3K |
|
3199
Microvision
MVIS
$88.5M
| $400K | ﹤0.01% |
23,380
+17,615
| +306% | +$305K |
|
3200
Lexicon Pharmaceuticals
LXRX
$1.07B
| $398K | ﹤0.01% |
420,700
+134,941
| +47% | +$87.4K |
|
Similar funds
Invesco's Q2 2025 Portfolio in Review
As of Q2 2025, Invesco held 3,922 positions worth $588B, up 11% from $528B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Invesco's Q2 2025 filing shows 165 new, 1,670 increased, 1,835 reduced and 165 closed positions. Its largest new stake was QXO Inc: 27,561,664 shares worth $594M. The largest sale was UnitedHealth, an estimated $701M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q2 2025 buy was QXO Inc: 27,561,664 shares worth $594M.
- Invesco added most to Microsoft in Q2 2025, an estimated $1.45B increase.
- Invesco's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $701M.
- Invesco fully exited Discover Financial Services in Q2 2025, selling an estimated $484M.
- Invesco's ten largest holdings make up 20% of its $588B portfolio in Q2 2025.
- Invesco opened 165 new positions and closed 165 in Q2 2025.
- Invesco's portfolio value rose 11% quarter-over-quarter to $588B.
Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.